[HPP-2.0] Indentification of proteomic biomarkers for immunotherapy in esophageal cancer
Ontology highlight
ABSTRACT: We established a cohort of neoadjuvant immunotherapy for esophageal cancer, using proteomics to obtain protein molecules associated with efficacy and capable of characterizing the microenvironment of esophageal cancer and verify their effect in predicting immunotherapy response in an independent neoadjuvant immunotherapy cohort or in the real world. Future prospective clinical trials will be conducted to verify the effect of screening populations.
ORGANISM(S): Homo Sapiens
SUBMITTER: Zhihao Lu
PROVIDER: PXD050172 | iProX | Mon Feb 26 00:00:00 GMT 2024
REPOSITORIES: iProX
ACCESS DATA